• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 4.0MM X 30MM NO TIP- PMA; STENT, INTRACRANIAL NEUROVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 4.0MM X 30MM NO TIP- PMA; STENT, INTRACRANIAL NEUROVASCULAR Back to Search Results
Model Number M003UZAS40300
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis (2100)
Date of Event 02/22/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Subject device remains implanted.
 
Event or Problem Description
It was reported that during stent-assisted coiling procedure for an aneurysm located at the right middle cerebral artery (mca), at main branching (trifurcation) with the subject stent, there was stent thrombosis due to platelet aggregation to the ostium of the stented branch.Resolved after injection of abciximab medication.According to the physician, the adverse event of stent thrombosis was assessed as serious adverse event and related to the subject stent and the index procedure.The adverse event was resolved without sequelae.
 
Additional Manufacturer Narrative
Due to the automated mes system there are controls in the manufacturing process to ensure the product met specifications upon release.The device was intended to be used for treatment.The reported event was unable to be confirmed and it cannot be confirmed that the device net specification, as the device was not returned.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The device was not returned.An assignable cause of anticipated procedural complication will be assigned to the reported event as a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted with the directions for use, product labeling and/or risk documentation files.
 
Event or Problem Description
It was reported that during stent-assisted coiling procedure for an aneurysm located at the right middle cerebral artery (mca), at main branching (trifurcation) with the subject stent, there was stent thrombosis due to platelet aggregation to the ostium of the stented branch.Resolved after injection of abciximab medication.According to the physician, the adverse event of stent thrombosis was assessed as serious adverse event and related to the subject stent and the index procedure.The adverse event was resolved without sequelae.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROFORM ATLAS 4.0MM X 30MM NO TIP- PMA
Common Device Name
STENT, INTRACRANIAL NEUROVASCULAR
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
MDR Report Key10242106
Report Number3008881809-2020-00197
Device Sequence Number19543429
Product Code NJE
UDI-Device Identifier07613327382181
UDI-Public07613327382181
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
P180031
Number of Events Summarized1
Summary Report (Y/N)Y
Device Implanted Year2018
Reporter Type Manufacturer
Report Source study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/31/2023
Device Model NumberM003UZAS40300
Device Catalogue NumberM003UZAS40300
Device Lot Number20226716
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/06/2020
Supplement Date Received by Manufacturer10/05/2020
Initial Report FDA Received Date07/07/2020
Supplement Report FDA Received Date10/06/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age59 YR
-
-